CClinicalTrials.gg
CompletedNCT07271095Updated Dec 9, 2025

Strengthening Numerical Skills and Medication Calculation Abilities of Nursing Students

An interventional study of Peer-supported medication calculation training in Student and Nursing, sponsored by Lokman Hekim University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-09.

Sponsored by Lokman Hekim University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled May 2024, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This experimental study aims to evaluate the effect of peer-assisted education on nursing students' numerical and drug calculation skills. A randomized controlled pretest-posttest design will be conducted with 55 first-year nursing students (27 in the experimental group and 28 in the control group). The experimental group will participate in a three-week peer education program focusing on numerical problem-solving and medication dosage calculations, led by trained mentor students.

02

Conditions studied

  • Student
  • Nursing

Keywords

  • Nursing education
  • peer education
  • Medication calculation
  • Numerical skills
03

In context

Lead sponsor

Lokman Hekim University is the lead sponsor of 41 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Students who were registered for the Fundamentals of Nursing course for the first time
  • Students who agreed to participate in the research voluntarily

Exclusion criteria

Exclusion Criteria:

  • Students who graduated from a Health Vocational High School
  • Students who had previous training in the health field
  • Students who had previously taken a Fundamentals of Nursing course
  • Students diagnosed with a psychiatric illness
  • Students who were regularly taking psychiatric medications
  • Students who did not attend the theoretical sessions of the course
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
55 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Peer-supported medication calculation training program

    Other: Peer-supported medication calculation training

  • No intervention
    Control Group

    Participants who received traditional lecture-based instruction

Interventions

  • OtherPeer-supported medication calculation training

    The intervention consisted of a peer-supported education program on medication dosage calculation, implemented over three weeks with five 60-minute sessions. In Week 1, four mentor students-senior nursing students with prior training in medication calculations and a GPA above 3.0-received refresher instruction from the course instructor. The training covered decimals, percentages, unit conversions, weight-based and non-weight-based dose calculations, and infusion pump adjustments, followed by sample problem-solving activities. The intervention group was divided into four subgroups, each consisting of 7-8 students, and each was assigned a consistent mentor. Each session included 30 minutes of individual and peer problem-solving followed by 30 minutes of guided mentoring. The course instructor provided supervision and feedback throughout the sessions. During Weeks 2 and 3, students practiced numerical and medication dosage calculations through peer-supported exercises.

06

What researchers measure

Primary outcomes

  1. The Medication Calculation Ability

    Medication Calculation Ability Assessment Form (Pre-Test, Post-Test): The pre-test consisted of eight questions. The posttest consisted of twenty questions, including additional questions similar to those in the pretest. The questions covered the following categories: * Dosage calculation for solid and liquid oral medications (3 questions in the pretest, 8 questions in the posttest), * Dosage calculation for injections (3 questions in the pretest, 7 questions in the posttest), * Calculation of percentage solutions and intravenous fluids (2 questions in the pretest, 5 questions in the posttest). Each correct answer was scored; the participants' correct answers were averaged to convert the score into a percentage. Thus, a medication calculation skill score ranging from 0% to 100% was obtained for each participant.

    Time frame: They were evaluated before the intervention and after 3 weeks of intervention.

Secondary outcomes

  1. The Numerical Skills

    Numerical Skills Assessment Form (Pre-Test, Post-Test): The pre-test consisted of five questions. The post-test consisted of 10 questions, including additional questions similar to those in the pre-test. The questions covered basic numerical skills, including addition, subtraction, multiplication, division, fractions, decimals, percentage calculations, and unit conversions. Each correct answer was scored, and the percentage score was converted by averaging the number of correct answers. Thus, a numerical skill score ranging from 0% to 100% was obtained for each participant.

    Time frame: They were evaluated both before and after the 3-week intervention.

07

Study locations

1 site
  • Lokman Hekim University
    Çankaya, Ankara 06510, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07271095
Lead sponsor
Lokman Hekim University
Responsible party
Beratiye Oner (Assistant Professor, Lokman Hekim University) — Principal investigator
First posted
Dec 9, 2025
Start date
May 15, 2024
Primary completion
Jun 15, 2024
Completion
Jun 20, 2024
Last update
Dec 9, 2025

Study contacts

Beratiye Oner
study director · Lokman Hekim University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion